Exogenous Recombinant Human BMP-2 Has Little Initial Effects on Human Osteoblastic Cells Cultured on Collagen Type I Coated/Noncoated Hydroxyapatite Ceramic Granules

Journal of Oral and Maxillofacial Surgery

Volumn 65, Issue 3, 2007, Pages 485-493

  Turhani, Dritan ^a   Weißenböck, Martina ^a   Stein, Elisabeth ^a   Wanschitz, Felix ^a   Ewers, Rolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; HYDROXYAPATITE; OSTEOCALCIN; POLYSTYRENE; PROTEIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL VIABILITY; CERAMICS; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA CELL; RED ALGA;

ALKALINE PHOSPHATASE; APOPTOSIS; BONE MORPHOGENETIC PROTEINS; BONE SUBSTITUTES; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; DURAPATITE; HUMANS; OSTEOBLASTS; OSTEOCALCIN; RECOMBINANT PROTEINS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33847267346     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2005.12.065     Document Type: Article

References (49)

1. Vacanti J.P., and Langer R. Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354 (1999) 32
2. Langer R., and Tirell D.A. Designing materials for biology and medicine. Nature 428 (2004) 487
3. Peppas N.A., and Langer R. New challenges in biomaterials. Science 263 (1994) 1715
4. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 21 (2000) 2529
5. Lutolf M.P., and Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotech 23 (2005) 47
6. LeGeros R.Z. Properties of osteoconductive biomaterials: Calcium phosphates. Clin Orthop Relat Res 395 (2002) 81
7. Hench L.L. Bioceramics. J Am Ceram Soc 81 (1998) 1705
8. Bucholz R.W. Nonallograft osteoconductive bone graft substitutes. Clin Orthop Relat Res 395 (2002) 44
9. Moreira-Gonzalez A., Jackson I.T., Miyawaki T., et al. Augmentation of the craniomaxillofacial region using porous hydroxyapatite granules. Plast Reconstr Surg 111 (2003) 1808
10. Wiltfang J., Kessler P., Buchfelder M., et al. Reconstruction of skull bone defects using the hydroxyapatite cement with calvarial split transplants. J Oral Maxillofac Surg 62 (2004) 29
11. Ewers R., and Schumann B. Experimental and clinical applications of Algipore, a phycogenic hydroxylapatite. J Craniomaxillofac Surg 22 (1994) 92
12. Schopper C., Moser D., Sabbas A., et al. The fluorohydroxyapatite (FHA) FRIOS Algipore is a suitable biomaterial for the reconstruction of severely atrophic human maxillae. Clin Oral Implants Res 6 (2003) 743
13. Ewers R., Goriwoda W., Schopper C., et al. Histologic findings at augmented bone areas supplied with two different bone substitute materials combined with sinus floor lifting. Report of one case. Clin Oral Implants Res 15 (2004) 96
14. Turhani D., Weißenböck M., Watzinger E., et al. In vitro study of adherent mandibular osteoblast-like cells on carrier materials. Int J Oral Maxillofac Surg 34 (2005) 543
15. Turhani D., Item C.B., Cvikl B., et al. In vitro growth and differentiation of osteoblast-like cells on C GRAFT/Algipore-A hydroxyapatite ceramic calcified from red algae. J Oral Maxillofac Surg 63 (2005) 793
16. Turhani D., Weißenböck M., Watzinger E., et al. Three dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation-An in vitro study. Clin Oral Implants Res 16 (2005) 417
17. Deuel T.F. Principles of Tissue Engineering (1997), Academic Press, New York 133
18. Parsons-Wingerter P.A., and Saltzman W.M. Growth versus function in the three-dimensional culture of single and aggregated hepatocytes within collagen gels. Biotechnol Prog 9 (1993) 600
19. Rosso F., Marino M., Giordano A., et al. Smart materials as scaffolds for tissue engineering. J Cell Physiol 203 (2005) 465
20. Kouml G.T., Korkusuz F., Ozkul A., et al. Tissue engineered cartilage on collagen and PHBV matrices. Biomaterials 26 (2005) 5187
21. Ber S., Torun Kose G., and Hasirci V. Bone tissue engineering on patterned collagen films: An in vitro study. Biomaterials 26 (2005) 1977
22. Wiesmann H.P., Nazer N., Klatt C., et al. Bone tissue engineering by primary osteoblast-like cells in a monolayer system and 3-dimensional collagen gel. J Oral Maxillofac Surg 61 (2003) 1455
23. Ignatius A., Blessing H., Liedert A., et al. Tissue engineering of bone: Effects of mechanical strain on osteoblastic cells in type I collagen matrices. Biomaterials 26 (2005) 311
24. Hanks T., and Atkinson B.L. Comparison of cell viability on anorganic bone matrix with or without P-15 cell binding peptide. Biomaterials 25 (2004) 4831
25. Benoit D.S.W., and Anseth K.S. The effect on osteoblast function of colocalized RGD and PHSRN epitopes on PEG surfaces. Biomaterials 26 (2005) 5209
26. Yang X.B., Roach H.I., Clarke N.M.P., et al. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 29 (2001) 523
27. Wozney J.M. Overview of bone morphogenetic proteins. Spine 27 (2002) 2
28. Urist M.R. Bone: Formation by autoinduction. Science 150 (1965) 893
29. Urist M.R. Bone morphogenetic protein: The molecularization of skeletal system development. J Bone Miner Res 12 (1997) 343
30. Reddi A.H. Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8 (1997) 11
31. Rosen V., and Wozney J.M. Bone morphogenetic proteins. In: Bilezikian J.P., Raisz L.G., and Rodan G.A. (Eds). Principles of Bone Biology (2002), Academic Press, New York 919
32. Winn S.R., Uludag H., and Hollinger J.O. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31 (1998) 303
33. Wikesjö U.M.E., Qahash M., Thomson R.C., et al. RhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 15 (2004) 194
34. Schmitt J.M., Hwang K., Winn S.R., et al. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthop Res 17 (1999) 269
35. Yudell R.M., and Block M.S. Bone gap healing in the dog using recombinant human bone morphogenetic protein-2. J Oral Maxillofac Surg 58 (2000) 761
36. Shupnik M.A., Antoniades H.N., and Tashjian Jr. A.H. Platelet-derived growth factor increases prostaglandin production and decreases epidermal growth factor receptors in human osteosarcoma cells. Life Sci 25 (1982) 347
37. Puleo D.A., and Nanci A. Understanding and controlling the bone-implant interface. Biomaterials 20 (1999) 2311
38. Masi L., Franchi A., Santucci M., et al. Adhesion, growth, and matrix production by osteoblasts on collagen substrata. Calcif Tissue Int 51 (1992) 202
39. Lynch M.P., Stein J.L., Stein G.S., et al. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: Modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization. Exp Cell Res 216 (1995) 35
40. Mori M., Isobe M., Yamazaki Y., et al. Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2. J Biomed Mat Res 50 (2000) 191
41. Sykaras N., Iacopino A.M., Triplett R.G., et al. Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: A biomechanics study. Clin Oral Invest 8 (2004) 196
42. Vehof J.W.M., Ruijter A.E., Spauwen P.H.M., et al. Influence of rhBMP-2 on rat bone marrow stromal cells cultured on titanium fiber mesh. Tissue Eng 7 (2001) 373
43. Rodrigues C.V.M., Serricella P., Linhares A.B.R., et al. Characterization of a bovine collagen-hydroxyapatite composite scaffold for bone tissue engineering. Biomaterials 27 (2003) 4987
44. Sakano S., Murata Y., Miura T., et al. Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop 292 (1993) 337
45. Takuwa Y., Ohse C., Wang E.A., et al. Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174 (1991) 96
46. Kim K.J., Itho T., and Kotke S. Effects of recombinant human bone morphogenetic protein-2 on human bone marrow cells cultured with various biomaterials. J Biomed Mat Res 35 (1997) 279
47. Yamaguchi A., Katagiri T., Ikeda T., et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113 (1991) 681
48. 2+-binding protein of bone matrix. Haemostasis 16 (1986) 258
49. Hay E., Lemonnier J., Fromigué O., et al. Bone morphogenetic protein receptor IB signalling mediates apoptosis independently of differentiation in osteoblastic cells. J Biol Chem 279 (2004) 1650